Skip to main content
. 2019 Sep;7(18):430. doi: 10.21037/atm.2019.08.117

Table 1. Basal characteristics and outcomes of patients with and without low skeletal muscle mass.

Variable Non-low skeletal muscle mass (N=95) Low skeletal muscle mass (N=421) P
Age, years 64.8±14.4 68.7±14.0 0.020
Male 54 (56.8) 289 (68.6) 0.028
BMI (kg/m2) 23.7±3.3 21.1±4.1 <0.001
SMI (cm2/m2) 57.5±15.1 33.4±10.1 <0.001
APACHE II 15.0±6.8 16.1±6.9 0.181
SOFA 8.2±4.4 8.2±4.0 0.999
CCI 4.2±2.5 4.3±2.2 0.808
Multiple vasopressor use 71 (74.7) 339 (80.5) 0.207
Renal replacement therapy 28 (29.5) 126 (29.9) 0.903
Lactate on admission 4.7±18.9 4.2±17.8 0.827
Infection source
   Respiratory 81 (85.3) 373 (88.6) 0.366
   Abdominal 9 (9.5) 30 (7.1) 0.434
   Urinary tract 14 (14.7) 49 (11.6) 0.405
   Soft tissue 8 (8.4) 20 (4.8) 0.154
Rehabilitation 52 (54.7) 215 (51.1) 0.518
Ventilator day 26.6±34.1 24.9±39.6 0.772
Hospital stay 44.4±45.4 54.8±63.0 0.065
ICU stay 17.4 ±23.4 19.3±23.9 0.492
In-hospital mortality 24 (25.3) 138 (32.8) 0.154
Discharge to home 56 (58.9) 166 (39.4) 0.001
6-month mortality 25 (26.3) 189 (44.9) 0.001
1 year mortality 31 (32.6) 211 (50.1) 0.002

Values are expressed as mean ± standard deviation or n (%). BMI, body mass index; SMI, skeletal muscle index; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; CCI, Charlson Comorbidity Index.